Erin Currie
Senior Associate
London
Erin Currie
Senior Associate
London
Contact details
Erin is an associate in the Intellectual Property Litigation team in London. She has gained experience working on contentious intellectual property matters, with a particular focus on patent litigation in the life sciences sector.
Erin has a BSc in Cell & Molecular Biology and has worked in biomedical research in Canada and the UK. At the University of British Columbia her work focussed on specialised cells in the olfactory system and their ability to stimulate neuronal regeneration following damage to the nervous system; her focus shifted to the regulation of haematopoietic stem cells in normal development and leukaemia at Cancer Research UK in London.
Her recent work includes acting for Eli Lilly in patent revocation proceedings relating to the dosage regimen of its blockbuster tadalafil product in first instance and appeal proceedings. She has subsequently assisted in co-ordinating multi-jurisdictional European litigation alongside completing a Postgraduate Diploma in Intellectual Property Law and Practice at the University of Oxford.
Related articles
Publications: 14 March 2022
Podcast: Strategies when litigating divisional patents
Why are divisional patent applications important to consider when litigating a parent patent?
Blog Post: 22 February 2022
Blog Post: 11 October 2021
Podcast: The injunction gap, proportionality and final injunctions: legislative updates in Germany
Published work
United Kingdom - Life Sciences, Getting the Deal Through, 2015
Different motile behaviours of human hematopoietic stem versus progenitor cells at the osteoblastic niche, Stem Cell Reports, 2015
APOBEC3A is implicated in a novel class of G-to-A mRNA editing in WT1 transcripts, PLoS One, 2015
CD34(-) cells at the apex of the human hematopoietic stem cell hierarchy have distinctive cellular and molecular signatures, Cell Stem Cell, 2013
Multimodal imaging reveals structural and functional heterogeneity in different bone marrow compartments: functional implications on hematopoietic stem cells, Blood, 2013
Semaphorin 5B mediates synapse elimination in hippocampal neurons, Neural Development, 2009
Undesired effects of a combinatorial treatment for spinal cord injury - transplantation of olfactory ensheathing cells and BDNF infusion to the red nucleus, European Journal of Neuroscience, 2008